Blue Light Cystoscopy With Cysview® Registry
Status: Recruiting
Location: See all (23) locations...
Intervention Type: Device, Drug
Study Type: Observational
SUMMARY
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Adult \>18 years old
• Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy
Locations
United States
Alabama
The University of Alabama at Birmingham
RECRUITING
Birmingham
Arizona
Mayo Clinic
RECRUITING
Phoenix
California
University of California Los Angeles
RECRUITING
Los Angeles
USC/Norris Comprehensive Cancer Center
RECRUITING
Los Angeles
VA Palo Alto Health Care System
RECRUITING
Palo Alto
University of California, San Francisco
RECRUITING
San Francisco
Washington, D.c.
Sibley Memorial Hospital
RECRUITING
Washington D.c.
Georgia
Emory University School of Medicine
RECRUITING
Atlanta
Illinois
Northwestern University
RECRUITING
Chicago
Northshore University Health System
RECRUITING
Evanston
Indiana
Indiana University School of Medicine
RECRUITING
Indianapolis
Kansas
University of Kansas Medical Center
RECRUITING
Kansas City
Maryland
Johns Hopkins Medicine
RECRUITING
Baltimore
Minnesota
University of Minnesota
RECRUITING
Minneapolis
New York
NYU Langone's Perlmutter Cancer Center
RECRUITING
New York
Stony Brook Urology
SUSPENDED
Stony Brook
Ohio
Ohio State University
RECRUITING
Columbus
Ohio State University Wexner Medical Center
RECRUITING
Columbus
South Carolina
Lexington Medical Center
RECRUITING
West Columbia
Texas
UT Southwestern
RECRUITING
Dallas
Michael E. DeBakey VA Medical Center
RECRUITING
Houston
Washington
University of Washington Medicine
RECRUITING
Seattle
West Virginia
Charleston Area Medical Center
TERMINATED
Charleston
Contact Information
Primary
Chad McKee, PhD
chad.mckee@photocure.com
(919) 780-0417
Time Frame
Start Date: 2014-04
Estimated Completion Date: 2028-12
Participants
Target number of participants: 4400
Treatments
Blue Light Cystoscopy with Cysview®
Bladder cancer patients who have undergone Blue light cystoscopy with Hexaminolevulinate hydrochloride (Cysview®) 100mg in 50 milliliters (mL) reconstituted solution instilled intravesically into bladder prior to cystoscopy in operating room (OR). Retention time: 1-3 hours. The Karl Storz D-Light C Photodynamic Diagnostic (PDD) system is used for the cystoscopy procedure at the OR examination.
Authors
Krishnanath Gaitonde, Hadley Wyre, Massimiliano Spaliviero, John Fitzgerald, Wayne Waltzer, Trinity Bivalacqua, Badrinath Konety, Vitaly Margulis, James Tierney, Samuel Deem, Phillip Pierorazio, Eugene Lee, Ganesh Raj
Related Therapeutic Areas
Sponsors
Leads: Photocure
Collaborators: Catalyst Pharmaceutical Research